Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Corticospinal Modulation

Sativex is an emergent treatment option for spasticity in patients affected by multiple sclerosis (MS). This oromucosal spray, acting as a partial agonist at cannabinoid receptors, may modulate the balance between excitatory and inhibitory neurotransmitters, leading to muscle relaxation that is in t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neural Plast
Egile Nagusiak: Russo, Margherita, Calabrò, Rocco Salvatore, Naro, Antonino, Sessa, Edoardo, Rifici, Carmela, D'Aleo, Giangaetano, Leo, Antonino, De Luca, Rosaria, Quartarone, Angelo, Bramanti, Placido
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi Publishing Corporation 2015
Gaiak:
Clinical Study
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4325203/
https://ncbi.nlm.nih.gov/pubmed/25699191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/656582
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak